Three technologies that will shape biotech in 2026
The Future of Biotech: Three Technologies that Will Shape the Industry in 2026
The field of biotechnology is rapidly evolving, with new breakthroughs and innovations emerging every year. In 2026, we can expect to see significant advancements in gene editing, ancient DNA analysis, and embryo screening. These technologies have the potential to revolutionize the way we approach healthcare, conservation, and human reproduction.
Gene Editing: The Future of Personalized Medicine
In August 2024, a breakthrough in gene editing technology was achieved with the birth of KJ Muldoon, a baby with a rare genetic disorder. KJ's parents were offered an experimental gene therapy, a personalized "base editing" treatment designed to correct the specific genetic "misspellings" responsible for his disease. The treatment was successful, and KJ is now thriving.
This achievement is a significant step forward in the field of gene editing, and it has the potential to revolutionize the way we approach personalized medicine. The team behind KJ's treatment is planning a clinical trial for infants with similar disorders caused by different genetic mutations. If successful, this could make the expensive treatment more accessible to a wider range of patients.
Fyodor Urnov, a gene-editing scientist at the University of California, Berkeley, is also working on developing gene-editing drugs for another disorder called phenylketonuria (PKU). The goal is to obtain regulatory approval for a single drug that can then be adjusted or personalized for individuals without having to go through more clinical trials.
US regulators seem to be amenable to the idea, and they have described a potential approval pathway for such "bespoke, personalized therapies." This is an exciting development, and it has the potential to make gene editing a more accessible and affordable treatment option for patients.
Ancient DNA Analysis: Unlocking the Secrets of the Past
Colossal Biosciences, a biotech company, is working on "de-extincting" animals like the woolly mammoth and the dodo. In March, the company created what it called "woolly mice," rodents with furry coats and curly whiskers akin to those of woolly mammoths. The company made an even more dramatic claim the following month, when it announced it had created three dire wolves.
The technology behind these creations is undeniably fascinating. It involves the extraction and analysis of ancient DNA, which can then be introduced into cells from other, modern-day species. This has applications not only in attempts to re-create dead pets but also in wildlife conservation efforts.
Analysis of ancient DNA can reveal all sorts of fascinating insights into human ancestors and other animals. For example, scientists have used ancient DNA to study the evolution of the human immune system and to identify the origins of the Neanderthals.
Embryo Screening: The Ethics of Selecting for Traits
Embryo screening has evolved in recent years, and it is now possible to select embryos for features like height, eye color, and even IQ. This is a highly controversial topic, and it raises many ethical questions.
Some critics warn of eugenics, and they argue that selecting for certain traits could lead to a loss of genetic diversity. Others note that whichever embryo you end up choosing, you can't control exactly how your baby will turn out.
Despite these concerns, companies like Nucleus are offering these services to prospective parents. They invite potential customers to "have their best baby," but this raises many questions about the ethics of selecting for traits.
Conclusion
The future of biotech is rapidly evolving, and we can expect to see significant advancements in gene editing, ancient DNA analysis, and embryo screening. These technologies have the potential to revolutionize the way we approach healthcare, conservation, and human reproduction.
However, they also raise many ethical questions, and it is essential that we consider the implications of these technologies before they become widespread. As we move forward, it is crucial that we prioritize transparency, accountability, and ethics in the development and deployment of these technologies.
Ultimately, the future of biotech is a complex and multifaceted issue, and it will require careful consideration and debate. As we navigate this landscape, it is essential that we prioritize the well-being of individuals, communities, and the environment.
